Genome-wide significant associations (P-value −8) for identified low-frequency and rare variants with EwS susceptibility using a dominant model stratified by study.
Aberrant alternative splicing, prevalent in cancer, impacts various cancer hallmarks involving proliferation, angiogenesis, and invasion. Splicing disruption often results from somatic point mutations
